Indications and uses
Cures most Athlete's foot (tinea pedis) Jock Itch (tinea cruris) Ringworm (tinea corporis) Effectively relieves Itching Cracking Burning Discomfort which can accompany these conditions
Cures most Athlete's foot (tinea pedis) Jock Itch (tinea cruris) Ringworm (tinea corporis) Effectively relieves Itching Cracking Burning Discomfort which can accompany these conditions
This product is not effective on the scalp or nails For best results, follow directions and continue treatment for length of time indicated. For athlete's foot and ringworm: use daily for 4 weeks. For jock itch: use daily for 2 weeks. clean the affected area and dry thoroughly apply a thin layer of the product over affected area twice daily (morning and night) or as directed by a doctor supervise children in the u...
CLOTRIMAZOLE -clotrimazolesolutionMarlexPharmaceuticals, Inc.
Disclaimer: Most OTC drugs are not reviewed and approved by FDA, however they may be marketed if they comply with applicable regulations and policies. FDA has not evaluated whether this product complies.
----------
ClotrimazoleTopical Solution USP,1%
Drug Facts
Clotrimazole USP, 1%
Antifungal
Cures most
Effectively relieves
Discomfort which can accompany these conditions
For external use only
on children under 2 years of age
avoid contact with eyes
If swallowed, get medical help or contact a Poison Control Center right away.
For athlete's foot: pay special attention to spaces between the toes; wear well-fitting, ventilated shoes; change shoes and socks at least once daily
polyethylene glycol
keep this carton for important information.
Manufactured for and Distributed by:
Marlex Pharmaceuticals, Inc.
New Castle, DE 19720
ϯ All trademarks are property of their respective owners. This product is not affiliated with the makers/owners of Lotrimin®AF.
Rev. 11/18 IT
Rev. 11/18 IT
NDC 10135-0671-81
Clotrimazole
Topical Solution
USP, 1 %
10 mL
Rev. 01/20 IT
NDC 10135-0671-91
Clotrimazole
Topical Solution
USP, 1 %
30 mL
| Class | Version | Type | Effective |
|---|---|---|---|
| CLOTRIMAZOLE Pharmacologic Class Indexing | 2 | Indexing - Pharmacologic Class | 20180813 |
| Product concept | Relation | Version | Effective |
|---|---|---|---|
| b64d2752-34ef-378a-1f4f-8bff32b0d1ae | Product name | 4 | 20250626 |
| cb7783e0-feaa-7e56-fb3b-d43b6efa77c9 | Product name | 2 | 20250121 |
| f31c883b-7ebf-1c60-f3b6-4ba41e8ff7a6 | Product name | 2 | 20151106 |
| f5395dd2-4395-d8c6-3477-8c2d4a2f951c | Product name | 1 | 20140508 |
| Package NDC | Product | Description | Form | Quantity | Strength | SPL version |
|---|---|---|---|---|---|---|
| 10135-671-81 | Clotrimazole | 10 mL in 1 BOTTLE | SOLUTION | 10 | 8 | |
| 10135-671-81 | Clotrimazole | 1 in 1 CARTON | SOLUTION | 1 | 8 | |
| 10135-671-91 | Clotrimazole | 1 in 1 CARTON | SOLUTION | 1 | 8 | |
| 10135-671-91 | Clotrimazole | 30 mL in 1 BOTTLE | SOLUTION | 30 | 8 |
| Package NDC | Billing unit | Product NDC | DailyMed indexing SPL | SPL version | Effective |
|---|---|---|---|---|---|
| 10135-671-81 | ML - Milliliter | 10135-671 | 20b9cd43-b3b8-45ab-b185-aa435e24717a | 1 | 2019-01-24 |
| 10135-671-91 | ML - Milliliter | 10135-671 | c004140e-3550-406d-8686-1fc7bb50526d | 1 | 2020-04-20 |
Every source-derived product name is available through these pages.
| Product NDC | Package NDC |
|---|---|
| 10135-671 | 10135-671-81, 10135-671-91 |
Every source-derived ingredient row is available through these pages.
| Name | UNII | Kind |
|---|---|---|
| POLYETHYLENE GLYCOL 400 | B697894SGQ | IACT |
| CLOTRIMAZOLE | G07GZ97H65 | ACTIB |
| Version | Effective date | Source | Hydrated |
|---|---|---|---|
| 7 | 2024-07-18 | full-release | 2026-06-01 00:15:36 |
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| Clotrimazole | CLOTRIMAZOLE | Marlex Pharmaceuticals Inc | d6e95c99-e055-436a-8ee6-40d6e199eaca | 2025-10-08 | Warnings | 10135-671-81 10135-671-91 10135-671 10135067181 10135067191 40a87948-bcf6-0552-e063-6394a90a2d0d d6e95c99-e055-436a-8ee6-40d6e199eaca |
Adverse event summaries are temporarily unavailable. Other product information remains available.